“…In recent years, researchers have intensively investigated on photothermal cancer therapy and have invested significant efforts to develop a wide variety of nanomaterial‐based photothermal agents and therapeutic approaches to achieve their goals. [ 36–44 ] Up to now, various types of inorganic nanomaterials have been developed for PTT, such as noble metals (e.g., Au, Ag, Pt), [ 39,45–51 ] transition metal‐based compounds (e.g., Ti‐, Mn‐, Cu‐, Si‐based compounds), [ 3,26,29,33,37,52–59 ] and metal–organic frameworks (MOFs). [ 60–63 ] However, some types of nanomaterials possess inherent drawbacks such as poor chemical stability, low photothermal conversion efficiency (PCE), high cost, or high toxicity, which greatly hinder their practical applications.…”